In cancer patients, overexpression of PQBP1 acts as a repressor of IFN-β promoter transcription produced by IFI16 and cGAS induction, resulting in blocked DNA signaling and reduced survival (Shannon et al., 2018). Here, PQBP1 is linked to cancer.